Search Results - "Tower-Rader, Albree"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM.

    Authors: Masri, Ahmad Barriales‐Villa, Roberto Elliott, Perry et al.

    Source: European Journal of Heart Failure. Sep2024, Vol. 26 Issue 9, p1993-1998. 6p.

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Prediction of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy using machine learning.

    Authors: Lu, Ree Lumish, Heidi S. Hasegawa, Kohei et al.

    Source: European Journal of Heart Failure. Feb2025, Vol. 27 Issue 2, p275-284. 10p.

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.

    Authors: Desai, Milind Y. Wolski, Kathy Owens, Anjali et al.

    Source: Circulation. 5/13/2025, Vol. 151 Issue 19, pe1001-e1001. 1p.

    Save to List
  4. 4

    Cardiac Tumors: Clinical Presentation, Diagnosis, and Management.

    Authors: Poterucha TJ Kochav J O'Connor DS et al.

    Source: Current treatment options in oncology [Curr Treat Options Oncol] 2019 Jun 27; Vol. 20 (8), pp. 66. Date of Electronic Publication: 2019 Jun 27.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List

Search Tools: